Steroid combination for septic shock
Treatments studied
Part of Infections clinical trials.
This trial tests whether two medicines (hydrocortisone and fludrocortisone) can help people with severe infections that cause dangerously low blood pressure (septic shock). It's for patients who have just been diagnosed and haven't used steroids recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 90 years old.
- You must have been diagnosed with septic shock within the last 12 hours.
- You cannot have taken any steroid medications in the past 3 months.
- You cannot be pregnant.
- You cannot have a known allergy to hydrocortisone or fludrocortisone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a steroid called fludrocortisone to standard care helps people with septic shock (a dangerous drop in blood pressure from infection) get better faster. If you are in the ICU, on a breathing machine, and need strong medication for your blood pressure, you may be eligible.
This Phase 3 trial tests whether giving stress-dose hydrocortisone can improve outcomes for children with septic shock in the pediatric intensive care unit (PICU). It is designed for children who are already receiving strong medicines to support blood pressure because of a serious infection.
This trial tests a new approach to treating septic shock, a life-threatening condition where infection causes dangerously low blood pressure. It aims to see if a different way of managing fluids and medications can improve recovery compared to standard care.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
This trial tests whether a combination of vitamins B6, B12, and C can help improve blood flow in tiny blood vessels (microcirculation) for people with sepsis. It may help your body recover better from severe infection.
This Phase 3 trial tests whether giving hydrocortisone plus fludrocortisone to critically ill ICU patients with suspected “corticosteroid insufficiency” can improve outcomes without relying on steroids already being used. It may help patients whose bodies aren’t making enough stress hormones during severe illness.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.